Sartorius grows operations in France and is investing 100 million euros by 2025
November 26, 2021
The Group will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry The site in Aubagne, Sartorius’ headquarters in France, will receive the major part of this investment to build new cleanrooms and R&D laboratories Sartorius will [...]
Introducing the new 6000 generation of 3D Atom Probes
November 26, 2021
Invizo 6000: The 3D Atom Probe with the largest field of view The Invizo 6000 3D Atom Probe microscope introduces major technology breakthroughs to push the boundaries of atom probe analysis. Its ultra wide field of view flight path and unique dual-beam deep UV laser pulse system result in higher single-specimen yield and a greater [...]
Spacetek – Cutting-edge time-of-flight gas analysis from Switzerland
November 25, 2021
Spacetek, a Swiss company from Gümligen close to Bern offers with the IonTamerTM-Series uncompromized gas analysis with an AMU range from 1 to 1.200 in a compact bolt-on design. The time-of-flight technology allows for ultrafast and dynamic control of gas compositions. The whole mass spectrum is recorded in snapshot mode, without sweeping through the masses. [...]
Sartorius significantly expands activities in South Korea
November 25, 2021
Göttingen -- The life science company Sartorius is investing around 270 million euros, some 300 million U.S. dollars, through the end of 2024 in expanding its activities in South Korea. In the country’s biopharma hub Songdo in Incheon, the company plans to launch cell culture media production and to assemble sterile systems for efficient and [...]
November 25, 2021
Shimadzu Corporation announces the release of LabSolutions MD, support software for analytical method development for high-performance liquid chromatography (HPLC). Strict quality control is required for pharmaceuticals, and this type of analysis is mainly performed using HPLC. Accurate, highly reliable analysis improves the safety of pharmaceuticals. Optimal analytical methods are developed by the pharmaceutical manufacturers. There [...]
Meridian Bioscience Announces Retirement of Chairman David Phillips
November 24, 2021
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022. The Board of Directors will elect [...]
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
November 24, 2021
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations for the company, effective Nov. 29. In this role, DeMartino will lead all aspects of communicating progress of the BD2025 strategy to investors and the [...]
November 24, 2021
CELLINK’s vision and dream is to be able to contribute to the future of medicine by addressing some of the key challenges in modern healthcare. It is well known that animal studies are poor indicators of success for human drug development, yet animals are still used in lengthy processes (average 12 years) with clinical trials [...]
Genoox to provide a genomic data analysis platform at Washington University in St. Louis
November 23, 2021
PALO ALTO, California, November 23, 2021 / PRNewswire / – Genoox, a company with the world’s largest community-driven genomic data platform, announced today that its genetic and genomic data management technology will be available to clinicians and researchers at University of Washington Faculty of Medicine in St. Louis, with the aim of promoting genomics-guided precision medicine. The Genoox platform includes the [...]
November 23, 2021
PARIS & BOSTON -- Stilla Technologies, the multiplex digital PCR company, today announced it has raised €31.3 million in the form of €11.3 million of convertible bonds and €20 million in loan financing. In addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement and Eurazeo, [...]

